Zhang H - Search Results

1

Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells.

Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K. Zhang H, et al. Cancer Sci. 2004 Nov;95(11):878-86. doi: 10.1111/j.1349-7006.2004.tb02197.x. Cancer Sci. 2004. PMID: 15546505 Free PMC article.

2

Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway.

Zhang H, Ozaki I, Mizuta T, Matsuhashi S, Yoshimura T, Hisatomi A, Tadano J, Sakai T, Yamamoto K. Zhang H, et al. Cancer. 2002 Aug 15;95(4):896-906. doi: 10.1002/cncr.10751. Cancer. 2002. PMID: 12209735 Free article.

3

Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2.

Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, Hisatomi A, Tadano J, Sakai T, Yamamoto K. Zhang H, et al. Hepatology. 2003 Aug;38(2):305-13. doi: 10.1053/jhep.2003.50345. Hepatology. 2003. PMID: 12883474 Free PMC article.

4

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.

Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K. Ozaki I, et al. Among authors: zhang h. Clin Cancer Res. 2007 Apr 1;13(7):2236-45. doi: 10.1158/1078-0432.CCR-06-2308. Clin Cancer Res. 2007. PMID: 17404108

5

Modulation of the transforming growth factor-beta1-induced Smad phosphorylation by the extracellular matrix receptor beta1-integrin.

Hamajima H, Ozaki I, Zhang H, Iwane S, Kawaguchi Y, Eguchi Y, Matsuhashi S, Mizuta T, Matsuzaki K, Fujimoto K. Hamajima H, et al. Among authors: zhang h. Int J Oncol. 2009 Dec;35(6):1441-7. doi: 10.3892/ijo_00000463. Int J Oncol. 2009. PMID: 19885568

6

Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.

Ide Y, Zhang H, Hamajima H, Kawaguchi Y, Eguchi Y, Mizuta T, Yamamoto K, Fujimoto K, Ozaki I. Ide Y, et al. Among authors: zhang h. Oncol Rep. 2009 Sep;22(3):599-604. doi: 10.3892/or_00000478. Oncol Rep. 2009. PMID: 19639210

7

Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1.

Ozaki I, Mizuta T, Zhao G, Zhang H, Yoshimura T, Kawazoe S, Eguchi Y, Yasutake T, Hisatomi A, Sakai T, Yamamoto K. Ozaki I, et al. Among authors: zhang h. Hepatol Res. 2003 Dec;27(4):289-301. doi: 10.1016/s1386-6346(03)00268-7. Hepatol Res. 2003. PMID: 14662117

8

Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.

Matsuhashi S, Hamajima H, Xia J, Zhang H, Mizuta T, Anzai K, Ozaki I. Matsuhashi S, et al. Among authors: zhang h. Cell Signal. 2014 Mar;26(3):603-10. doi: 10.1016/j.cellsig.2013.11.038. Epub 2013 Dec 12. Cell Signal. 2014. PMID: 24334270

9

Vitamin K2 augments 5-fluorouracil-induced growth inhibition of human hepatocellular carcinoma cells by inhibiting NF-κB activation.

Zhang H, Ozaki I, Hamajima H, Iwane S, Takahashi H, Kawaguchi Y, Eguchi Y, Yamamoto K, Mizuta T. Zhang H, et al. Oncol Rep. 2011 Jan;25(1):159-66. Oncol Rep. 2011. PMID: 21109972

10

[Expression of programmed cell death 4 and its clinicopathological significance in human pancreatic cancer].

Ma G, Guo KJ, Zhang H, Ozaki I, Matsuhashi S, Zheng XY, Dong M. Ma G, et al. Among authors: zhang h. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):597-600. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005. PMID: 16274040 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129,752 results

Search Page

Filters